SynthesisCancer biology & medicine2020

Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.

Runsen Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.